Cherry Mammen presenting on AKI in DKA. Approx 50% of DKA have AKI, and approx 28% have severe AKI. RRT is uncommon (4%) but neurocog outcomes are poorer at 3-6 months.
Cherry Mammen presenting on AKI in DKA. Approx 50% of DKA have AKI, and approx 28% have severe AKI. RRT is uncommon (4%) but neurocog outcomes are poorer at 3-6 months.
#PSANZ
#PSANZ
First up Simon Carter from RCH Melbourne discusses antenatal counselling of antenatally detected kidney disease. #NKC #ANZNKC #preservethenephrons
First up Simon Carter from RCH Melbourne discusses antenatal counselling of antenatally detected kidney disease. #NKC #ANZNKC #preservethenephrons
James M. Ervasti & team report treatment of dystrophin-deficient skeletal muscle with hydrogen sulfide fully protects against eccentric contraction-induced force loss:
buff.ly/H7LDGq2
#PSANZ
www.babykidney.org/chapters/aus...
#PSANZ
www.babykidney.org/chapters/aus...
✔️ AKI in cancer patients
✔️ The impact of novel oncology therapies
✔️ Drug dosing considerations in kidney-compromised cancer patients
Listen here: bit.ly/3DamjQ9
@silvishah.bsky.social
@gudnephron.bsky.social
✔️ AKI in cancer patients
✔️ The impact of novel oncology therapies
✔️ Drug dosing considerations in kidney-compromised cancer patients
Listen here: bit.ly/3DamjQ9
@silvishah.bsky.social
@gudnephron.bsky.social
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
www.podbean.com/ew/pb-zr9r3-...
www.podbean.com/ew/pb-zr9r3-...
academic.oup.com/ndt/advance-...
academic.oup.com/ndt/advance-...
Type A SLC3A1 is more common (and sometimes associated with a contiguous gene deletion including PREL1), and SLC7A9 less common. #IPNA2025
Type A SLC3A1 is more common (and sometimes associated with a contiguous gene deletion including PREL1), and SLC7A9 less common. #IPNA2025
Things you mightn’t know can increase the blood pressure, crossed legs, watching the phone, TALKING!!
Things you mightn’t know can increase the blood pressure, crossed legs, watching the phone, TALKING!!
50% C3+. IgG1/4 -primary. C1q - consider LN.
50% C3+. IgG1/4 -primary. C1q - consider LN.